Assembly Bill A8212

2021-2022 Legislative Session

Limits the off label use of antipsychotic drugs on elderly patients with dementia

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

2021-A8212 (ACTIVE) - Details

See Senate Version of this Bill:
S6462
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Add §280-d, Pub Health L; amd §6530, Ed L
Versions Introduced in 2023-2024 Legislative Session:
A3374, S5704

2021-A8212 (ACTIVE) - Summary

Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.

2021-A8212 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8212
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                              August 25, 2021
                                ___________
 
 Introduced  by M. of A. HYNDMAN -- read once and referred to the Commit-
   tee on Health
 
 AN ACT to amend the public health law, in relation to limiting  the  off
   label  use  of  antipsychotic drugs with black box warnings on elderly
   patients with dementia; and to amend the education law, in relation to
   professional medical misconduct

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  The  public health law is amended by adding a new section
 280-d to read as follows:
   § 280-D. USE OF ANTIPSYCHOTIC DRUGS ON ELDERLY PATIENTS WITH DEMENTIA.
 1. AS USED IN THIS SECTION:
   (A) "OFF  LABEL"  MEANS  A  MEDICAL  PRACTICE  IN  WHICH  A  PHYSICIAN
 PRESCRIBES A DRUG FOR A DIFFERENT MEDICAL PURPOSE THAN THE ONE FOR WHICH
 SUCH DRUG IS APPROVED FOR;
   (B) "BLACK BOX WARNING" MEANS A WARNING ISSUED BY THE FEDERAL FOOD AND
 DRUG  ADMINISTRATION  AND PLACED ON THE PACKAGE INSERT OF A PRESCRIPTION
 DRUG THAT MAY BE FATAL OR CAUSE SERVER SIDE EFFECTS;
   (C)  "CHEMICAL  RESTRAINT"  MEANS  WHEN  AN  ANTIPSYCHOTIC  DRUG  THAT
 PROVIDES  NO  MEDICAL  BENEFIT TO A PATIENT WITH DEMENTIA AND IS USED TO
 SEDATE SUCH PATIENT, CONTROL SUCH PATIENT'S BEHAVIOR  OR  RESTRICT  SUCH
 PATIENT'S MOVEMENT;
   (D)  "ANTIPSYCHOTIC  DRUG" MEANS ANY TYPICAL OR ATYPICAL ANTIPSYCHOTIC
 DRUG THAT IS INTENDED TO BE USED ON PATIENTS WITH  MENTAL  ILLNESS  THAT
 REQUIRE  A BLACK BOX WARNING AND SHALL INCLUDE BUT NOT BE LIMITED TO THE
 FOLLOWING:
   (I) TYPICAL ANTIPSYCHOTIC DRUGS: HALOPERIDOL, LOXAPINE,  THIORIDAZINE,
 MOLINDONE,  THIOTHIXENE,  FLUPHENAZINE, TRIFLUOPERAZINE, CHLORPROMAZINE,
 PERPHENAZINE, OR PROMOZIDE; OR
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD11120-01-1

              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.